OVATURE (OVArian TUmor REsponse) A Phase III Study of Weekly Carboplatin With and Without Phenoxodiol in Patients With Platinum-Resistant, Recurrent Epithelial Ovarian Cancer
Public ClinicalTrials.gov record NCT00382811. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Multi-Center, Randomized, Double-Blind, Phase III Efficacy Study Comparing Phenoxodiol in Combination With Carboplatin Versus Carboplatin With Placebo in Patients With Platinum-Resistant or Platinum-Refractory Late-Stage Epithelial Ovarian, Fallopian or Primary Peritoneal Cancer Following at Least Second Line Platinum Therapy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this project is to see if weekly carboplatin compared with phenoxodiol in combination with weekly carboplatin, is effective against late stage ovarian cancer and to see what, if any, side-effects of treatment may result.
Study identification
- NCT ID
- NCT00382811
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 142 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2006 (Type not available)
- Primary completion
- Apr 2009 (Actual)
- Completion
- Apr 2011 (Actual)
- Last update posted
- Jul 18, 2016
2006 – 2011
United States locations
- U.S. sites
- 37
- U.S. states
- 18
- U.S. cities
- 35
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Clinical Research Center, Inc. | Tuscon | Arizona | 85715 | — |
| Glendale Adventist | Glendale | California | 91206 | — |
| Kaiser Permanente Los Angeles Medical Center | Los Angeles | California | 90027 | — |
| Cedars-Sinai Medical Center | Los Angeles | California | 90048 | — |
| Gynecology Oncology Associates | Newport Beach | California | 92663 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06520 | — |
| Hematology Oncology, PC (Carl and Dorothy Bennett Cancer Center) | Stamford | Connecticut | 06902 | — |
| Gynecologic Oncology Associates | Pembroke Pines | Florida | 33028 | — |
| Piedmont Hospital | Atlanta | Georgia | 30309 | — |
| Medical College of Georgia Cancer Center | Augusta | Georgia | 30912 | — |
| Associates in Women's Health | Wichita | Kansas | 67214 | — |
| Hematology and Oncology Specialists, LLC | Metairie | Louisiana | 70006 | — |
| Greater Baltimore Medical Centre | Baltimore | Maryland | 21204 | — |
| Gynecologic Oncology of West Michigan | Grand Rapids | Michigan | 49546 | — |
| Providence Hospital and Medical Centers | Southfield | Michigan | 48075 | — |
| The Center for Cancer & Hematological Disease | Cherry Hill | New Jersey | 08003 | — |
| Jersey Shore Medical Center | Neptune City | New Jersey | 07754 | — |
| The University of New Mexico Cancer Research and Treatment Center | Albuquerque | New Mexico | 87131-0001 | — |
| Schwartz Gynecologic Oncology | Brightwaters | New York | 11718 | — |
| New York Downtown Hospital | New York | New York | 10038 | — |
| University of Rochester Gynecologic Oncology Associates | Rochester | New York | 14620 | — |
| Carolinas Medical Center | Charlotte | North Carolina | 28204 | — |
| Brody School of Medical at East Carolina University | Greenville | North Carolina | 27834 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| Gabrail Cancer Center | Canton | Ohio | 44718 | — |
| MetroHealth Medical Center | Cleveland | Ohio | 44109 | — |
| OSU James Cancer Hospital & Solove Research Institute | Columbus | Ohio | 43210 | — |
| Miami Valley Hospital | Dayton | Ohio | — | — |
| Chattanooga GYN Oncology | Chattanooga | Tennessee | 37403 | — |
| Chattanooga's Program In Women's Oncology | Chattanooga | Tennessee | 37403 | — |
| Hall and Martin MDS, P.C. | Knoxville | Tennessee | 37920 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| Hope Cancer Clinic | Brownsville | Texas | 78526 | — |
| University of Texas Southwestern Medical Center Simmons Comprehensive Cancer Center | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Northern Virginia Pelvic Surgery Associates | Annadale | Virginia | 22003 | — |
| Virginia Mason Medical Center Department of Hematology/Oncology | Seattle | Washington | 98101 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 33 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00382811, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 18, 2016 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00382811 live on ClinicalTrials.gov.